Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
29.96
+0.13 (0.44%)
Mar 20, 2026, 1:35 PM CST

SHA:688566 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
964.93896.53860.93654.73509.69
Revenue Growth (YoY)
7.63%4.13%31.49%28.46%-9.94%
Cost of Revenue
-95.2697.1876.1762.12
Gross Profit
964.93801.28763.76578.56447.57
Selling, General & Admin
-458.54459.86361.56304.65
Research & Development
-38.6555.7755.1829.28
Other Operating Expenses
712.1712.9810.479.249.1
Operating Expenses
712.17512.43533.31426.71341.26
Operating Income
252.76288.85230.44151.85106.32
Interest Expense
--0.13-0.11-0.38-
Interest & Investment Income
-5.412.0217.7721.64
Other Non Operating Income (Expenses)
45.45-0.11-0.14-0.07-0.11
EBT Excluding Unusual Items
298.21294.01242.22169.18127.85
Gain (Loss) on Sale of Investments
--1.05-1.9--
Gain (Loss) on Sale of Assets
----0.01-
Asset Writedown
--42.24---
Other Unusual Items
-2.657.165.374.71
Pretax Income
298.21253.36247.48174.53132.56
Income Tax Expense
39.5534.3928.7120.2718.22
Earnings From Continuing Operations
258.67218.98218.77154.26114.35
Minority Interest in Earnings
-0.350.320.40.55
Net Income
258.67219.33219.09154.67114.9
Net Income to Common
258.67219.33219.09154.67114.9
Net Income Growth
17.94%0.11%41.65%34.61%-11.42%
Shares Outstanding (Basic)
199194187186188
Shares Outstanding (Diluted)
199194187186188
Shares Change (YoY)
2.51%3.65%0.49%-1.07%11.81%
EPS (Basic)
1.301.131.170.830.61
EPS (Diluted)
1.301.131.170.830.61
EPS Growth
15.04%-3.42%40.96%36.07%-20.78%
Free Cash Flow
-40.76-197.87-141.9866.77
Free Cash Flow Per Share
-0.21-1.06-0.760.35
Dividend Per Share
-0.780-0.4800.480
Gross Margin
100.00%89.38%88.71%88.37%87.81%
Operating Margin
26.20%32.22%26.77%23.19%20.86%
Profit Margin
26.81%24.46%25.45%23.62%22.54%
Free Cash Flow Margin
-4.55%-22.98%-21.68%13.10%
EBITDA
263.36299.45241.65164.6119.3
EBITDA Margin
27.29%33.40%28.07%25.14%23.41%
D&A For EBITDA
10.610.611.212.7512.98
EBIT
252.76288.85230.44151.85106.32
EBIT Margin
26.20%32.22%26.77%23.19%20.86%
Effective Tax Rate
13.26%13.57%11.60%11.62%13.74%
Revenue as Reported
-896.53860.93654.73509.69
Advertising Expenses
---153.2121.29
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.